Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
33,289,095
-
Number of holders
-
21
-
Total 13F shares, excl. options
-
1,108,524
-
Shares change
-
-394,061
-
Total reported value, excl. options
-
$5,632,279
-
Value change
-
-$1,834,365
-
Number of buys
-
9
-
Number of sells
-
-9
-
Price
-
$5.08
Significant Holders of XBiotech Inc. - Common Shares, no par value (XBIT) as of Q4 2018
27 filings reported holding XBIT - XBiotech Inc. - Common Shares, no par value as of Q4 2018.
XBiotech Inc. - Common Shares, no par value (XBIT) has 21 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,108,524 shares
of 33,289,095 outstanding shares and own 3.33% of the company stock.
Largest 10 shareholders include Vanguard Group Inc (437,606 shares), GEODE CAPITAL MANAGEMENT, LLC (135,163 shares), EAM Investors, LLC (125,566 shares), BlackRock Inc. (88,061 shares), MILLENNIUM MANAGEMENT LLC (49,036 shares), DIMENSIONAL FUND ADVISORS LP (45,659 shares), NORTHERN TRUST CORP (44,471 shares), STATE STREET CORP (23,159 shares), Tudor Investment Corp Et Al (21,218 shares), and BOOTHBAY FUND MANAGEMENT, LLC (21,079 shares).
This table shows the top 21 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.